StockCIK 1630627

TREACE MEDICAL CONCEPTS, INC. (TMCI): Insider Trades and Fund Holdings

In the past 12 months, TREACE MEDICAL CONCEPTS, INC. insiders reported 3 open-market purchases worth $247K and 0 sales worth $0.

3Insider buys, 12 months

$247KBought by insiders, 12 months

$0Sold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 24, 2026.

Recent TMCI insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Aug 24	Aug 20	John T. TreaceCEO	CEO	▲ BUY	39,944	4.44	$177K	+0.5%	Form 4 ↗
Aug 24	Aug 24	John T. TreaceCEO	CEO	▲ BUY	11,000	4.34	$48K	+0.1%	Form 4 ↗
Aug 24	Aug 21	John T. TreaceCEO	CEO	▲ BUY	5,000	4.35	$22K	+0.1%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
John T. Treace	CEO	3	$247K	0	$0	Aug 24, 2026

Tracked funds that report TMCI

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	48,300	$192K	0.00%	▼ −90.8%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →